Glioblastoma – Current Concepts, Prognostic Markers And Molecular Classification
Glioblastoma (GBM) has very poor prognosis despite aggressive therapy including surgical treatment. At present, few molecular markers could clarify GBM prognosis in greater detail. However, better understanding of the molecular pathogenesis would be the mainstay of improved, more personalized treatm...
Gespeichert in:
Veröffentlicht in: | Latvijas k̦̦irurg̓ijas žurnāls 2013-12, Vol.13 (2), p.58-64 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 64 |
---|---|
container_issue | 2 |
container_start_page | 58 |
container_title | Latvijas k̦̦irurg̓ijas žurnāls |
container_volume | 13 |
creator | Jakovlevs, Arvids Vanags, Andrejs Balodis, Dainis Gardovskis, Janis Strumfa, Ilze |
description | Glioblastoma (GBM) has very poor prognosis despite aggressive therapy including surgical treatment. At present, few molecular markers could clarify GBM prognosis in greater detail. However, better understanding of the molecular pathogenesis would be the mainstay of improved, more personalized treatment modalities. Recent large-scale molecular studies brought new data that altered previous concepts about GBM; even molecular subtypes of GBM have been discovered. We discuss here the classic pathology of GBM along with molecular markers and subtypes of GBM as well as routine applications of these advances. |
doi_str_mv | 10.2478/chilat-2014-0012 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1857808316</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4299394021</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1658-c0e244d3be493bc9cea586e6adec5b60f4f7da5e1d69a7f2b180bf6d5100018b3</originalsourceid><addsrcrecordid>eNp1kL9OwzAQhy0EElXpzmiJlYD_xLEzMFQRFKRWIAQSm-U4l5KSxsV2hLrxDrwhT0KqMrBwy93w--5OH0KnlFywVKpL-9q0JiaM0DQhhLIDNGI0zxMhuTxEI5oSmeSKvhyjSQgrMhTPmeRihB5nbePK1oTo1gZ_f37hovceuogL11nYxHCOH7xbdi7ExuKF8W_gA552FV64FmzfGo-LgQ9N3VgTG9edoKPatAEmv32Mnm-un4rbZH4_uyum88TSTKjEEmBpWvES0pyXNrdghMogMxVYUWakTmtZGQG0ynIja1ZSRco6qwQd3qeq5GN0tt-78e69hxD1yvW-G05qqoRURHGaDSmyT1nvQvBQ641v1sZvNSV6J0_v5emdPL2TNyBXe-TDtBF8BUvfb4fhz_5_UMqZUPwH6M55bQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1857808316</pqid></control><display><type>article</type><title>Glioblastoma – Current Concepts, Prognostic Markers And Molecular Classification</title><source>De Gruyter Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Jakovlevs, Arvids ; Vanags, Andrejs ; Balodis, Dainis ; Gardovskis, Janis ; Strumfa, Ilze</creator><creatorcontrib>Jakovlevs, Arvids ; Vanags, Andrejs ; Balodis, Dainis ; Gardovskis, Janis ; Strumfa, Ilze</creatorcontrib><description>Glioblastoma (GBM) has very poor prognosis despite aggressive therapy including surgical treatment. At present, few molecular markers could clarify GBM prognosis in greater detail. However, better understanding of the molecular pathogenesis would be the mainstay of improved, more personalized treatment modalities. Recent large-scale molecular studies brought new data that altered previous concepts about GBM; even molecular subtypes of GBM have been discovered. We discuss here the classic pathology of GBM along with molecular markers and subtypes of GBM as well as routine applications of these advances.</description><identifier>ISSN: 1407-981X</identifier><identifier>EISSN: 2199-5737</identifier><identifier>EISSN: 1407-981X</identifier><identifier>DOI: 10.2478/chilat-2014-0012</identifier><language>eng</language><publisher>Riga: De Gruyter Open</publisher><subject>Brain cancer ; Glioblastoma ; Medical prognosis ; Molecular biology ; molecular subtypes ; prognostic markers ; Tumorigenesis</subject><ispartof>Latvijas k̦̦irurg̓ijas žurnāls, 2013-12, Vol.13 (2), p.58-64</ispartof><rights>Copyright De Gruyter Open Sp. z o.o. 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.degruyter.com/document/doi/10.2478/chilat-2014-0012/pdf$$EPDF$$P50$$Gwalterdegruyter$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.degruyter.com/document/doi/10.2478/chilat-2014-0012/html$$EHTML$$P50$$Gwalterdegruyter$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,27924,27925,67030,68814</link.rule.ids></links><search><creatorcontrib>Jakovlevs, Arvids</creatorcontrib><creatorcontrib>Vanags, Andrejs</creatorcontrib><creatorcontrib>Balodis, Dainis</creatorcontrib><creatorcontrib>Gardovskis, Janis</creatorcontrib><creatorcontrib>Strumfa, Ilze</creatorcontrib><title>Glioblastoma – Current Concepts, Prognostic Markers And Molecular Classification</title><title>Latvijas k̦̦irurg̓ijas žurnāls</title><description>Glioblastoma (GBM) has very poor prognosis despite aggressive therapy including surgical treatment. At present, few molecular markers could clarify GBM prognosis in greater detail. However, better understanding of the molecular pathogenesis would be the mainstay of improved, more personalized treatment modalities. Recent large-scale molecular studies brought new data that altered previous concepts about GBM; even molecular subtypes of GBM have been discovered. We discuss here the classic pathology of GBM along with molecular markers and subtypes of GBM as well as routine applications of these advances.</description><subject>Brain cancer</subject><subject>Glioblastoma</subject><subject>Medical prognosis</subject><subject>Molecular biology</subject><subject>molecular subtypes</subject><subject>prognostic markers</subject><subject>Tumorigenesis</subject><issn>1407-981X</issn><issn>2199-5737</issn><issn>1407-981X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNp1kL9OwzAQhy0EElXpzmiJlYD_xLEzMFQRFKRWIAQSm-U4l5KSxsV2hLrxDrwhT0KqMrBwy93w--5OH0KnlFywVKpL-9q0JiaM0DQhhLIDNGI0zxMhuTxEI5oSmeSKvhyjSQgrMhTPmeRihB5nbePK1oTo1gZ_f37hovceuogL11nYxHCOH7xbdi7ExuKF8W_gA552FV64FmzfGo-LgQ9N3VgTG9edoKPatAEmv32Mnm-un4rbZH4_uyum88TSTKjEEmBpWvES0pyXNrdghMogMxVYUWakTmtZGQG0ynIja1ZSRco6qwQd3qeq5GN0tt-78e69hxD1yvW-G05qqoRURHGaDSmyT1nvQvBQ641v1sZvNSV6J0_v5emdPL2TNyBXe-TDtBF8BUvfb4fhz_5_UMqZUPwH6M55bQ</recordid><startdate>20131201</startdate><enddate>20131201</enddate><creator>Jakovlevs, Arvids</creator><creator>Vanags, Andrejs</creator><creator>Balodis, Dainis</creator><creator>Gardovskis, Janis</creator><creator>Strumfa, Ilze</creator><general>De Gruyter Open</general><general>De Gruyter Poland</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope></search><sort><creationdate>20131201</creationdate><title>Glioblastoma – Current Concepts, Prognostic Markers And Molecular Classification</title><author>Jakovlevs, Arvids ; Vanags, Andrejs ; Balodis, Dainis ; Gardovskis, Janis ; Strumfa, Ilze</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1658-c0e244d3be493bc9cea586e6adec5b60f4f7da5e1d69a7f2b180bf6d5100018b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Brain cancer</topic><topic>Glioblastoma</topic><topic>Medical prognosis</topic><topic>Molecular biology</topic><topic>molecular subtypes</topic><topic>prognostic markers</topic><topic>Tumorigenesis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jakovlevs, Arvids</creatorcontrib><creatorcontrib>Vanags, Andrejs</creatorcontrib><creatorcontrib>Balodis, Dainis</creatorcontrib><creatorcontrib>Gardovskis, Janis</creatorcontrib><creatorcontrib>Strumfa, Ilze</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Nursing & Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>Latvijas k̦̦irurg̓ijas žurnāls</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jakovlevs, Arvids</au><au>Vanags, Andrejs</au><au>Balodis, Dainis</au><au>Gardovskis, Janis</au><au>Strumfa, Ilze</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glioblastoma – Current Concepts, Prognostic Markers And Molecular Classification</atitle><jtitle>Latvijas k̦̦irurg̓ijas žurnāls</jtitle><date>2013-12-01</date><risdate>2013</risdate><volume>13</volume><issue>2</issue><spage>58</spage><epage>64</epage><pages>58-64</pages><issn>1407-981X</issn><eissn>2199-5737</eissn><eissn>1407-981X</eissn><abstract>Glioblastoma (GBM) has very poor prognosis despite aggressive therapy including surgical treatment. At present, few molecular markers could clarify GBM prognosis in greater detail. However, better understanding of the molecular pathogenesis would be the mainstay of improved, more personalized treatment modalities. Recent large-scale molecular studies brought new data that altered previous concepts about GBM; even molecular subtypes of GBM have been discovered. We discuss here the classic pathology of GBM along with molecular markers and subtypes of GBM as well as routine applications of these advances.</abstract><cop>Riga</cop><pub>De Gruyter Open</pub><doi>10.2478/chilat-2014-0012</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1407-981X |
ispartof | Latvijas k̦̦irurg̓ijas žurnāls, 2013-12, Vol.13 (2), p.58-64 |
issn | 1407-981X 2199-5737 1407-981X |
language | eng |
recordid | cdi_proquest_journals_1857808316 |
source | De Gruyter Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Brain cancer Glioblastoma Medical prognosis Molecular biology molecular subtypes prognostic markers Tumorigenesis |
title | Glioblastoma – Current Concepts, Prognostic Markers And Molecular Classification |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T02%3A32%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glioblastoma%20%E2%80%93%20Current%20Concepts,%20Prognostic%20Markers%20And%20Molecular%20Classification&rft.jtitle=Latvijas%20k%CC%A6%CC%A6irurg%CC%93ijas%20%C5%BEurn%C4%81ls&rft.au=Jakovlevs,%20Arvids&rft.date=2013-12-01&rft.volume=13&rft.issue=2&rft.spage=58&rft.epage=64&rft.pages=58-64&rft.issn=1407-981X&rft.eissn=2199-5737&rft_id=info:doi/10.2478/chilat-2014-0012&rft_dat=%3Cproquest_cross%3E4299394021%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1857808316&rft_id=info:pmid/&rfr_iscdi=true |